Patents by Inventor Mohan Prasad

Mohan Prasad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150073148
    Abstract: The present invention relates to a process for the preparation of crystalline vilazodone hydrochloride.
    Type: Application
    Filed: April 16, 2013
    Publication date: March 12, 2015
    Inventors: Prasenjit Prafulla Das, Bindu Srivastava, Nitin Maheshwari, Hashim Nizar Poovanathil Nagoor Meeran, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20150031732
    Abstract: The present invention provides a solid dispersion of febuxostat, processes for its preparation, pharmaceutical compositions comprising it and its use for the chronic management of hyperuricemia in patients with gout.
    Type: Application
    Filed: April 16, 2012
    Publication date: January 29, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Poonam Kaushik, Ram Thaimattam, Mohan Prasad
  • Publication number: 20150025080
    Abstract: The present invention provides processes for the preparation of amorphous form of sitagliptin dihydrogen phosphate. It also provides a solid dispersion of sitagliptin dihydrogen phosphate, including in the amorphous form, and processes for its preparation.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 22, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Poonam Kaushik, Ram Thaimattam, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20150011774
    Abstract: The present invention relates to a process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: January 30, 2013
    Publication date: January 8, 2015
    Inventors: Md Abul Kalam Azad, Prakash Bhimaji Kshirsagar, Shravan Kumar Singh, Anand Prakash Tiwari, Kaptan Singh, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20140377362
    Abstract: Compositions that include a clay such as kaolin dispersed in a liquid such as water may be useful for promoting the clotting of blood. The compositions may be in a liquid, gel, paste, foam, or another form. Uses may include treating a traumatic injury such as in injury caused by a bullet, an explosive, a blade etc., or an injury caused during a medical procedure such as surgery.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Inventors: Mohan Prasad Pahari, Giacomo Basadonna, Denny Lo
  • Publication number: 20140378472
    Abstract: The present invention relates to amorphous vilazodone hydrochloride, its process of preparation and pharmaceutical composition thereof.
    Type: Application
    Filed: December 12, 2012
    Publication date: December 25, 2014
    Inventors: Poonam Kaushik, Ram Thaimattam, Mohan Prasad, Sudershan Kumar Arora
  • Patent number: 8916713
    Abstract: An improved and efficient process for the preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid (febuxostat) that is substantially free from amide by-product is provided.
    Type: Grant
    Filed: July 15, 2011
    Date of Patent: December 23, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Pranab Chatterjee, Asok Nath, Sarbjot Singh Sokhi, Mohan Prasad
  • Publication number: 20140357870
    Abstract: The present invention relates to a process for the preparation of dexlansoprazole.xH2O, wherein x is about 0.0 to about 0.1, using dexlansoprazole.xH2O, wherein x is about 2.6 to about 50.
    Type: Application
    Filed: June 20, 2012
    Publication date: December 4, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anmol Kumar Ray, Anu Mittal, Nagaraju Gottumukkala, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20140350255
    Abstract: The present invention relates to a process for the preparation of vilazodone or its pharmaceutically acceptable salts. The present invention further provides a crystalline form of vilazodone free base.
    Type: Application
    Filed: February 1, 2013
    Publication date: November 27, 2014
    Inventors: Prasenjit Prafulla Das, Bindu Srivastava, Nitin Maheshwari, Hashim Nizar Poovanathil Nagoor Meeran, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20140343290
    Abstract: The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2S,3R)-4-chloro-3-hydroxy-phenylbutan-2-yl]carbamate (Formula II) into 1-[4-(pyridine-2-yl)-phenyl]-4(S)-5 hydroxy-2-N-tert-butoxycarbonylamino-5(S)—N—(N-methoxycarbonyl-(L)-tert-leucyl)amino-6-phenyl-2-azahexane (Formula VII) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt.
    Type: Application
    Filed: July 25, 2012
    Publication date: November 20, 2014
    Inventors: Rakesh Kumar Singh, Nagaraju Gottumukkala, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad, Sudershan Kumar Arora
  • Publication number: 20140336380
    Abstract: The present invention provides a process for the preparation of agomelatine and its intermediate compounds. The invention also provides an intermediate compound of agomelatine represented by Formula (V).
    Type: Application
    Filed: November 21, 2012
    Publication date: November 13, 2014
    Inventors: Anu Mittal, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad, Sudershan Kumar Arora
  • Patent number: 8871932
    Abstract: The present invention relates to a process for the preparation of tadalafil of Formula I, comprising reacting a D-tryptophan compound of Formula III with piperonal in sulfolane.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: October 28, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Dattatray Bapuso Patil, Killol Patel, Ashok Prasad, Mohan Prasad
  • Patent number: 8858969
    Abstract: Compositions that include a clay such as kaolin dispersed in a liquid such as water may be useful for promoting the clotting of blood. The compositions may be in a liquid, gel, paste, foam, or another form. Uses may include treating a traumatic injury such as in injury caused by a bullet, an explosive, a blade etc., or an injury caused during a medical procedure such as surgery.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: October 14, 2014
    Assignee: Z-Medica, LLC
    Inventors: Mohan Prasad Pahari, Giacomo Basadonna, Denny Lo
  • Patent number: 8853411
    Abstract: The present invention relates to a process for the preparation of crystalline dexlansoprazole.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: October 7, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anu Mittal, Anmol Kumar Ray, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad
  • Patent number: 8816072
    Abstract: The present invention provides a process for preparation of crystalline aprepitant having not more than 15% by weight of Form I content which comprises, a) dissolving aprepitant in a suitable solvent to obtain a solution, b) cooling the solution to 10-15° C., c) optionally seeding the solution with aprepitant Form I crystals, d) adding an anti-solvent to the solution, and e) isolating crystalline aprepitant having not more than 15% by weight of Form I content.
    Type: Grant
    Filed: June 2, 2010
    Date of Patent: August 26, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Deepak Mohanlal Jain, Maneck Khurana, Hiten Sharadchandra Mehta, Abhay Tatiya, Asok Nath, Sanjay Mahadeo Gade, Mohan Prasad, Subhash Dhar
  • Publication number: 20140187569
    Abstract: The present invention relates to crystalline forms of bosentan salts and processes for their preparation.
    Type: Application
    Filed: March 4, 2014
    Publication date: July 3, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rakesh SINGH, Anu MITTAL, Gopal Singh BISHT, Mahavir Singh KHANNA, Rajesh Kumar THAPER, Mohan PRASAD
  • Publication number: 20140187568
    Abstract: The present invention relates to crystalline forms of bosentan salts and processes for their preparation.
    Type: Application
    Filed: March 4, 2014
    Publication date: July 3, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rakesh SINGH, Anu MITTAL, Gopal Singh BISHT, Mahavir Singh KHANNA, Rajesh Kumar THAPER, Mohan PRASAD
  • Patent number: 8759586
    Abstract: The present invention provides processes and intermediates for preparing cinacalcet base and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: June 24, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Sayeed Mukhtar, Dinesh Shashidharan Nair, Roshan Ramesh Medhane, Nitin Maheshwari, Hashim Nizar Poovanathil Nagoor Meeran, Neera Tewari, Mohan Prasad
  • Publication number: 20140142309
    Abstract: The present invention relates to a process for the preparation of a cis-intermediate compound of Formula II which is a useful synthetic intermediate for the preparation of tadalafil of Formula I—a potent, selective, and reversible inhibitor of cyclic guanosine 3?,5?-monophosphate specific phosphodiesterase type 5 enzyme having phosphodiesterase inhibitory activity.
    Type: Application
    Filed: April 10, 2013
    Publication date: May 22, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Dattatray B. PATIL, Killol Patel, Ashok Prasad, Mohan Prasad
  • Publication number: 20140135515
    Abstract: Methods for recovering free fatty acids from fats and oils having high free fatty acid content are provided. In the method, fats and oils are treated with a mixture having an alcohol to result in a low-free fatty acid oily phase and an alcohol phase. The mixture may also include an alkali. The alcohol may be a monohydric alcohol and an aqueous alcohol, such as an aqueous alcohol having a concentration of at least about 15% alcohol by weight. The alcohol phase may be treated with an acid to form an aqueous alcohol phase and a lipid alcohol phase, wherein the lipid alcohol phase includes free fatty acids, which may be recovered. Fats and oils amenable to such a method may include, but are not limited to, waste fats, waste oils, high acid grease, high acid tallow, and corn oil, such as corn oil produced at an ethanol production plant.
    Type: Application
    Filed: November 13, 2013
    Publication date: May 15, 2014
    Applicant: RIVERHEAD RESOURCES, LLC
    Inventors: Mohan Prasad A. Dasari, Kidron Joel Knox